Physician profile
Dieula John
NPI 1861954265
$953.25
in general payments reported to CMS, 2019-2025
8 companies · $540 in 2025
The $540 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.81 · 2023: $140 · 2024: $253 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $305.71 | 2024-2025 | Tepezza, Evenity |
| Novo Nordisk INC | $289.87 | 2022-2025 | Ozempic, Rybelsus, Sogroya |
| Tandem Diabetes Care, INC. | $118.45 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Corcept Therapeutics | $100.63 | 2023 | Korlym |
| Radius Health, INC. | $49.54 | 2024 | Tymlos |
| Xeris Pharmaceuticals, INC. | $48.41 | 2024 | Recorlev |
| Madrigal Pharmaceuticals | $25.83 | 2025 | Rezdiffra |
| Tolmar, INC. | $14.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dieula John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.